Vol. 14 No. 3 | March 2014

Vol. 14 No. 3 | March 2014

ISBN: 1526-5161

target articles

Addressing the Ethical Challenges in Genetic Testing and Sequencing of Children

Ellen Wright Clayton, Laurence B. McCullough, Leslie G. Biesecker, Steven Joffe, Lainie Friedman Ross, Susan M. Wolf & For the Clinical Sequencing Exploratory Research (CSER) Consortium Pediatrics Working Group

American Academy of Pediatrics (AAP) and American College of Medical Genetics (ACMG) recently provided two recommendations about predictive genetic testing of children. The Clinical Sequencing Exploratory Research Consortium’s Pediatrics Working Group compared these recommendations, focusing on operational and ethical issues specific to decision making for children. Content analysis of the s...

Click for More

Open Peer Commentary

Predictive Genomic Testing of Children for Adult Onset Disorders: A Canadian Perspective Michael J. Szego, M. Stephen Meyn, James A. Anderson, Robin Hayeems, Cheryl Shuman, Nasim Monfared, Sarah Bowdin & Randi Zlotnik Shaul
The Right to an Open Future Concerning Genetic Information Annelien L. Bredenoord, Martine C. de Vries & Hans van Delden
In the Absence of Evidentiary Harm, Existing Societal Norms Regarding Parental Authority Should Prevail Kimberly A. Strong, Arthur R. Derse, David P. Dimmock, Kaija L. Zusevics, Jessica Jeruzal, Elizabeth Worthey, David Bick, Gunter Scharer, Alison La Pean Kirschner, Ryan Spellecy, Michael H. Farrell, Jennifer Geurts, Regan Veith & Thomas May
Genetic Testing of Children: The Need for a Family Perspective Anneke Lucassen, Guy Widdershoven, Suzanne Metselaar, Angela Fenwick & Michael Parker
Empirical Ethics: The “Missing Link” in Incidental Findings Recommendations Gabrielle Christenhusz, Koenraad Devriendt & Kris Dierickx

The Ethics of Advertising for Health Care Services

Yael Schenker, Robert M. Arnold & Alex John London

Advertising by health care institutions has increased steadily in recent years. While direct-to-consumer prescription drug advertising is subject to unique oversight by the Federal Drug Administration, advertisements for health care services are regulated by the Federal Trade Commission and treated no differently from advertisements for consumer goods. In this article, we argue that decisions abou...

Click for More